Premium
Addition of low‐dose decitabine to bortezomib and dexamethasone as second‐line therapy in multiple myeloma
Author(s) -
Li Ning,
Liu Lina,
Xiang Pu,
Liang Lijie,
Wang Juan,
Wang Yaomei,
Luo Suxia,
Song Yongping,
Fang Baijun
Publication year - 2020
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.16686
Subject(s) - decitabine , bortezomib , multiple myeloma , dexamethasone , second line therapy , medicine , oncology , pharmacology , chemotherapy , chemistry , dna methylation , biochemistry , gene expression , gene